On Thursday, Shares of XOMA Corp ( NASDAQ:XOMA), gained 43.67% to $1.08.
XOMA Corporation declared recently it has exclusively licensed the global development and commercialization rights to its anti-transforming growth factor-beta (TGFb) antibody program to Novartis. Under the terms of the agreement, XOMA will receive $37.0 million in the form of an upfront payment and is eligible to receive up to $480.0 million if all development, regulatory, and commercial milestones are met. In addition, XOMA is eligible to receive royalties on product sales that range from the mid-single digits to the low double digits. In connection with this license agreement, Novartis has agreed to extend the maturity date on the about $13.5 million of outstanding debt under the secured note agreement, which bears interest at the six-month LIBOR plus 2% (presently 2.53%), to September 30, 2020. XOMA has also agreed to reduce the royalty rate to XOMA associated with Novartis’ clinical stage anti-CD40 antibodies.
XOMA Corporation is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead product candidate, gevokizumab, is a potent, humanized allosteric-modulating monoclonal antibody that binds to the inflammatory cytokine interleukin-1 beta (IL-1 beta). The Company has initiated three pivotal clinical trials evaluating gevokizumab for the treatment of non-infectious intermediate, posterior or pan-uveitis (NIU) and Behcet’s disease uveitis.
Shares of Helix Energy Solutions Group Inc (NYSE:HLX), inclined 1.04% to $4.84, during its last trading session.
Helix Energy Solutions Group will issue a press release reporting its financial and operational results for the third quarter of 2015 on Monday, October 19, 2015 after the market closes. After its issuance, a copy of the press release will be available on Helix’s website, www.HelixESG.com, by clicking on “For The Investor” and choosing “Press Releases”.
Helix will host a conference call to review its first quarter results on Tuesday, October 20, 2015 at 9:00 a.m. (CDT). Investors and other interested parties are encouraged to listen to the call via an audio webcast from the “For The Investor” page of our website, www.HelixESG.com. Investors and other interested parties wishing to listen to the conference call may join by dialing 800-917-9985 for persons in the United States and 1-212-231-2933 for international participants. The passcode is “Tripodo”.
Helix Energy Solutions Group, Inc. is an international offshore energy services company. The Company operates in four business segments: Well Intervention, Robotics, Production Facilities and Subsea Construction. Well Intervention segment comprises its vessels and equipment used to perform well intervention services primarily in the Gulf of Mexico and North Sea regions.
Shares of Texas Instruments Incorporated (NASDAQ:TXN), declined -2.18% to $48.44, during its last trading session.
Delivering optimal battery life while reducing power consumption, Texas Instruments (TI) (TXN) recently introduced a highly integrated battery administration solution presenting the industry’s lowest quiescent current (Iq) at 700-nA with the buck converter, operating at 1.8V. The bq25120 features a linear charger, configurable LDO, load switch, buck converter, pushbutton control and battery voltage monitor all in one. The solution supports batteries from 3.6-V to 4.65-V, and fast charge currents from 5-mA to 300-mA, allowing wearables and industrial Internet of Things (IoT) applications to always be on without draining the battery. \
Availability and pricing
The bq25120 charger is shipping in volume production and available through the TI Store and the company’s authorized distribution network. The product comes in a 2.5-mm by 2.5-mm, WCSP package. The bq25120 is priced at US$1.60 in 1,000-unit quantities.
Texas Instruments Incorporated designs, makes and sells semiconductors to electronics designers and manufacturers across the world. The Company operates through two segments: Analog and Embedded Processing. The Company’s Analog segment comprises the following product lines: High Volume Analog & Logic, Power Administration, High Performance Analog and Silicon Valley Analog.
Finally, PMC-Sierra Inc (NASDAQ:PMCS), ended its last trade with 7.09% gain, and closed at $7.25.
Chipmaker PMC-Sierra Inc is looking to sell itself and has hired financial adviser Qatalyst Partners to assist in the process, according to people familiar with the matter, according to Reuters.
The sales process is in its early stages and the company’s plans could still change, the people said, asking not to be named because the matter is private.
Representatives for Qatalyst and PMC-Sierra were not right away available for comment. Reuters Reports
PMC-Sierra, Inc. (PMC) is a semiconductor and software solution innovator transforming netoperates that connect, move, and store Big Data. The Company designs, develops, markets and supports semiconductor, embedded software, and board level solutions.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
